520 related articles for article (PubMed ID: 16574280)
1. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.
Grudzien A; Shaw P; Weintraub S; Bigio E; Mash DC; Mesulam MM
Neurobiol Aging; 2007 Mar; 28(3):327-35. PubMed ID: 16574280
[TBL] [Abstract][Full Text] [Related]
2. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.
Guillozet AL; Weintraub S; Mash DC; Mesulam MM
Arch Neurol; 2003 May; 60(5):729-36. PubMed ID: 12756137
[TBL] [Abstract][Full Text] [Related]
3. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
4. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.
Mesulam M; Shaw P; Mash D; Weintraub S
Ann Neurol; 2004 Jun; 55(6):815-28. PubMed ID: 15174015
[TBL] [Abstract][Full Text] [Related]
6. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
7. Dogs with canine counterpart of Alzheimer's disease lose noradrenergic neurons.
Insua D; Suárez ML; Santamarina G; Sarasa M; Pesini P
Neurobiol Aging; 2010 Apr; 31(4):625-35. PubMed ID: 18573571
[TBL] [Abstract][Full Text] [Related]
8. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
9. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.
Bennett DA; Schneider JA; Wilson RS; Bienias JL; Arnold SE
Arch Neurol; 2004 Mar; 61(3):378-84. PubMed ID: 15023815
[TBL] [Abstract][Full Text] [Related]
10. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
11. Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm?
Imhof A; Kövari E; von Gunten A; Gold G; Rivara CB; Herrmann FR; Hof PR; Bouras C; Giannakopoulos P
J Neurol Sci; 2007 Jun; 257(1-2):72-9. PubMed ID: 17303173
[TBL] [Abstract][Full Text] [Related]
12. [Neuropathology of Alzheimer's disease and mild cognitive impairment].
López OL; DeKosky ST
Rev Neurol; 2003 Jul 16-31; 37(2):155-63. PubMed ID: 12938076
[TBL] [Abstract][Full Text] [Related]
13. The neuropathological changes associated with normal brain aging.
Hof PR; Glannakopoulos P; Bouras C
Histol Histopathol; 1996 Oct; 11(4):1075-88. PubMed ID: 8930649
[TBL] [Abstract][Full Text] [Related]
14. Sex-dependent cytoskeletal changes of the human hypothalamus develop independently of Alzheimer's disease.
Schultz C; Ghebremedhin E; Braak E; Braak H
Exp Neurol; 1999 Nov; 160(1):186-93. PubMed ID: 10630203
[TBL] [Abstract][Full Text] [Related]
15. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction.
Yu CH; Song GS; Yhee JY; Kim JH; Im KS; Nho WG; Lee JH; Sur JH
J Comp Pathol; 2011 Jul; 145(1):45-58. PubMed ID: 21256508
[TBL] [Abstract][Full Text] [Related]
16. Tau protein abnormalities associated with the progression of alzheimer disease type dementia.
Haroutunian V; Davies P; Vianna C; Buxbaum JD; Purohit DP
Neurobiol Aging; 2007 Jan; 28(1):1-7. PubMed ID: 16343696
[TBL] [Abstract][Full Text] [Related]
17. Neuropathology of aminergic nuclei in Alzheimer's disease.
Zweig RM; Ross CA; Hedreen JC; Steele C; Cardillo JE; Whitehouse PJ; Folstein MF; Price DL
Prog Clin Biol Res; 1989; 317():353-65. PubMed ID: 2602423
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.
Riley KP; Snowdon DA; Markesbery WR
Ann Neurol; 2002 May; 51(5):567-77. PubMed ID: 12112102
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.
Togo T; Akiyama H; Iseki E; Uchikado H; Kondo H; Ikeda K; Tsuchiya K; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2004 Jun; 107(6):504-8. PubMed ID: 15024583
[TBL] [Abstract][Full Text] [Related]
20. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
